McNeil Expands Recalls

The FDA has announced that McNeil Consumer Healthcare has expanded its voluntary over-the-counter drug recalls to include additional types of Tylenol, as well as certain formulations of Motrin, Rolaids, Benedryl, Simply Sleep, and St. Joseph’s aspirin.  The recall includes Children’s Tylenol Meltaways and Children’s Motrin caplets and chewables.

A full list of recalled products and the lots has been posted on the FDA site.

Consumers have noticed a moldy, musty, or mildew-like smell when opening the medicines that has sometimes been associated with nausea, vomiting, stomach pain or diarrhea.  Effects have been temporary and not serious.

McNeil has traced the odor to small amounts of a chemical called 2,4,6-tribromoanisole (TBA).  TBA results from a breakdown of a chemical that is sometimes applied to wood pallets used to store and transport cases of the over-the-counter drugs.

The health effects of TBA haven’t been well-studied, according to McNeil, but there are no reports in medical literature of serious problems connected with it.  However, the company is continuing to investigate the issue and will no longer use pallets treated with TBA-associated chemicals to ship products.  They have also asked companies who ship supplies to their plants not to use treated pallets.

More information about the product recall is on the McNeil Product Recall website including:

McNeil tells consumers not to empty unused medicines in the sink, toilet, or storm drain.  If possible, they should be taken to a pharmacy or community “take-back” program.  Otherwise, they should be securely sealed in an unrecognizable container where children or pets do not have access and thrown in household trash.

A link to SMARxTDisposal.Net has more information about safely disposing of unused medicines.  SMARxT recommends combining medicines with kitty litter, coffee grounds, or similar materials to make them less attractive for children or pets to eat.

More information can be obtained by calling McNeil Consumer Healthcare at 888-222-6036.

Bookmark and Share

This news article was originally posted on January 19th, 2010 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on January 19th, 2010
Tags: FDA recalls, McNeil, Tylenol

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe